Chronopharmacology AI Engine ChronoDrug Launches: Optimizing the Best Time to Take Every Medication Based on the Human Body Clock

Chronopharmacology AI Engine ChronoDrug Launches: Optimizing the Best Time to Take Every Medication Based on the Human Body Clock

Novartis and Google Health have jointly launched the ChronoDrug chronopharmacology AI platform. The platform analyzes patients' circadian clock genotypes, real-time physiological data collected from wearable devices, and pharmacokinetic models to recommend the optimal timing window for each medication.

ChronoDrug's core finding is that the same medication taken at different times of day can vary in efficacy by 30-50%. For example, statins taken at bedtime are 40% more effective than when taken in the morning, because hepatic cholesterol synthesis peaks at night.

Berta Romero, Chief Digital Officer at Novartis, said: "Chronopharmacology isn't a new concept, but ChronoDrug makes it actionable for the first time. Doctors no longer need to suggest 'take after meals' based on experience — they can obtain precise, personalized dosing time recommendations down to the hour."

In a controlled trial of 5,000 patients, hypertensive patients using ChronoDrug to optimize their dosing times saw their blood pressure control rate improve from 68% to 89%, while average medication dosage was reduced by 20%.

ChronoDrug has been integrated into the digital labels of 30 of Novartis's commonly used medications, allowing patients to scan a code to receive personalized dosing time recommendations.